PURPOSE: Cancer mortality is approximately twice as high in Latin American countries than in more developed countries. In particular, the countries of the high Andean region of Latin America carry a double burden of breast and cervical cancers. In these countries, there are disproportionately higher mortality to incidence ratios compared with other regions in Latin America. The US National Cancer Institute's Center for Global Health, the Pan American Health Organization, and the Ministry of Health in Peru collaborated to design and execute an education and advocacy workshop in Lima, Peru. The workshop was convened to discuss regional challenges and practices, as well as to support the implementation of Plan Esperanza, Peru's national cancer control plan. METHODS: Workshop participants included local and international experts to present the state of the science, health practitioners, and advocacy groups to discuss unique barriers that women in the region experience. RESULTS: Inequalities in access to and distribution of medical expertise, lack of continuity of cancer control plans, and the need for sustained public buy-in emerged as obstacles. CONCLUSION: The workshop provided a forum to discuss key issues regarding breast and cervical cancer control among health professionals and advocates in Peru and the region. This article outlines the resulting recommendations.
PURPOSE:Cancer mortality is approximately twice as high in Latin American countries than in more developed countries. In particular, the countries of the high Andean region of Latin America carry a double burden of breast and cervical cancers. In these countries, there are disproportionately higher mortality to incidence ratios compared with other regions in Latin America. The US National Cancer Institute's Center for Global Health, the Pan American Health Organization, and the Ministry of Health in Peru collaborated to design and execute an education and advocacy workshop in Lima, Peru. The workshop was convened to discuss regional challenges and practices, as well as to support the implementation of Plan Esperanza, Peru's national cancer control plan. METHODS: Workshop participants included local and international experts to present the state of the science, health practitioners, and advocacy groups to discuss unique barriers that women in the region experience. RESULTS: Inequalities in access to and distribution of medical expertise, lack of continuity of cancer control plans, and the need for sustained public buy-in emerged as obstacles. CONCLUSION: The workshop provided a forum to discuss key issues regarding breast and cervical cancer control among health professionals and advocates in Peru and the region. This article outlines the resulting recommendations.
Authors: Paul E Goss; Brittany L Lee; Tanja Badovinac-Crnjevic; Kathrin Strasser-Weippl; Yanin Chavarri-Guerra; Jessica St Louis; Cynthia Villarreal-Garza; Karla Unger-Saldaña; Mayra Ferreyra; Márcio Debiasi; Pedro E R Liedke; Diego Touya; Gustavo Werutsky; Michaela Higgins; Lei Fan; Claudia Vasconcelos; Eduardo Cazap; Carlos Vallejos; Alejandro Mohar; Felicia Knaul; Hector Arreola; Rekha Batura; Silvana Luciani; Richard Sullivan; Dianne Finkelstein; Sergio Simon; Carlos Barrios; Rebecca Kightlinger; Andres Gelrud; Vladimir Bychkovsky; Gilberto Lopes; Stephen Stefani; Marcelo Blaya; Fabiano Hahn Souza; Franklin Santana Santos; Alberto Kaemmerer; Evandro de Azambuja; Andres Felipe Cardona Zorilla; Raul Murillo; Jose Jeronimo; Vivien Tsu; Andre Carvalho; Carlos Ferreira Gil; Cinthya Sternberg; Alfonso Dueñas-Gonzalez; Dennis Sgroi; Mauricio Cuello; Rodrigo Fresco; Rui Manuel Reis; Guiseppe Masera; Raúl Gabús; Raul Ribeiro; Renata Knust; Gustavo Ismael; Eduardo Rosenblatt; Berta Roth; Luisa Villa; Argelia Lara Solares; Marta Ximena Leon; Isabel Torres-Vigil; Alfredo Covarrubias-Gomez; Andrés Hernández; Mariela Bertolino; Gilberto Schwartsmann; Sergio Santillana; Francisco Esteva; Luis Fein; Max Mano; Henry Gomez; Marc Hurlbert; Alessandra Durstine; Gustavo Azenha Journal: Lancet Oncol Date: 2013-04 Impact factor: 41.316
Authors: Kathrin Strasser-Weippl; Yanin Chavarri-Guerra; Cynthia Villarreal-Garza; Brittany L Bychkovsky; Marcio Debiasi; Pedro E R Liedke; Enrique Soto-Perez-de-Celis; Don Dizon; Eduardo Cazap; Gilberto de Lima Lopes; Diego Touya; Joāo Soares Nunes; Jessica St Louis; Caroline Vail; Alexandra Bukowski; Pier Ramos-Elias; Karla Unger-Saldaña; Denise Froes Brandao; Mayra E Ferreyra; Silvana Luciani; Angelica Nogueira-Rodrigues; Aknar Freire de Carvalho Calabrich; Marcela G Del Carmen; Jose Alejandro Rauh-Hain; Kathleen Schmeler; Raúl Sala; Paul E Goss Journal: Lancet Oncol Date: 2015-10 Impact factor: 41.316
Authors: Alfredo Aguilar; Joseph A Pinto; Jhajaira Araujo; Williams Fajardo; Leny Bravo; Luis Pinillos; Carlos Vallejos Journal: Mol Clin Oncol Date: 2016-06-10
Authors: Andrea Thoumi; Sarah J Bond; Mary Elizabeth Dotson; Marlee Krieger; Patricia J Garcia; Nirmala Ramanujam Journal: Ann Glob Health Date: 2021-11-24 Impact factor: 2.462